69 Views | 43 Downloads
Izzuddin M. Aris, PhD, Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 401 Park Dr, Ste 401E, Boston, MA 02215. Email: izzuddin_aris@harvardpilgrim.org
Dr Aris had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Aris, Perng, Dabelea, Joseph, James, Oken. Acquisition, analysis, or interpretation of data: Aris, Padula, Alshawabkeh, Vélez-Vega, Aschner, Camargo, Sussman, Dunlop, Elliott, Ferrara, Zhu, Joseph, Singh, Hartert, Cacho, Karagas, North-Reid, Lester, Kelly, Ganiban, Chu, O’Connor, Fry, Norman, Trasande, Restrepo, James, Oken. Drafting of the manuscript: Aris, Vélez-Vega, Lester, Fry, Restrepo. Critical revision of the manuscript for important intellectual content: Aris, Perng, Dabelea, Padula, Alshawabkeh, Aschner, Camargo, Sussman, Dunlop, Elliott, Ferrara, Zhu, Joseph, Singh, Hartert, Cacho, Karagas, North-Reid, Kelly, Ganiban, Chu, O’Connor, Fry, Norman, Trasande, James, Oken. Statistical analysis: Aris, Perng. Obtained funding: Aris, Dabelea, Alshawabkeh, Aschner, Camargo, Dunlop, Elliott, Ferrara, Singh, Hartert, Karagas, Lester, Ganiban, O’Connor, Fry, Oken. Administrative, technical, or material support: Dabelea, Vélez-Vega, Dunlop, Singh, Cacho, Lester, O’Connor, Trasande, Restrepo, James, Oken. Supervision: Elliott, Singh, Fry, Oken.
Dr Alshawabkeh reported receiving grants from Northeastern University during the conduct of the study. Dr Aschner reported owning stock in Gilead Sciences outside the submitted work. Dr Sussman reported receiving grants from the Brain and Behavior Research Foundation and the National Institute on Drug Abuse during the conduct of the study. Dr Singh reported serving on the advisory board of Incyte Corporation and the data safety monitoring board of Siolta Therapeutics outside the submitted work. Dr Hartert reported receiving personal fees from Pfizer and Sanofi outside the submitted work. No other disclosures were reported.